U.S. Hospitality Stock News

NYSE:TYL
NYSE:TYLSoftware

Did Lake County’s Mobile Rollout Just Shift Tyler Technologies’ (TYL) Government Cloud Adoption Narrative?

Tyler Technologies, Inc. recently announced that the Lake County Sheriff’s Office in Illinois has gone live with its Enterprise Public Safety suite, including Enforcement Mobile, Civil Serve, and Corrections Mobile, giving officers real-time access to digital records and reducing manual data entry. This rollout shows how Tyler’s mobile and cloud-based tools can materially reshape daily workflows for a large public safety agency serving more than 720,000 residents. Next, we’ll examine how...
NYSE:RYAN
NYSE:RYANInsurance

Is Ryan Specialty Holdings (RYAN) Pricing Look Interesting After Recent Share Price Weakness?

Wondering whether Ryan Specialty Holdings at US$35.40 is starting to look interesting on price, or if the recent weakness is a warning sign? This article breaks down what the current valuation is actually telling you. The stock has seen a 5.3% decline over the last 7 days, a 5.6% gain over the last 30 days, and returns of 30.1% decline year to date and 48.7% decline over the last year. This raises questions about how sentiment and risk are shifting around the name. Recent coverage has...
NYSE:FAF
NYSE:FAFInsurance

First American Financial (FAF) Margin Rebound Tests Bullish Profitability Narratives Ahead Of Q1 2026

First American Financial (FAF) has followed up its earnings rebound with trailing 12‑month revenue of about US$7.5 billion and basic EPS of US$6.02, alongside year‑over‑year reported earnings growth of very roughly 4x and a net profit margin of 8.3% versus 2.1% a year earlier. The company has seen quarterly revenue move from US$1,406.1 million in Q3 2024 to US$1,685.1 million in Q4 2024 and then to US$2,049.7 million in Q4 2025, with basic EPS shifting from a loss of US$1.00 in Q3 2024 to...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Missile Unit Draws US$1b Investment And Potential IPO Rerating

L3Harris Technologies (NYSE:LHX) received a $1b investment from the Department of War into its Missile Solutions business. The funding is structured as a convertible preferred security that is set to convert to equity at a planned IPO of the Missile Solutions unit. Capital is earmarked for facility expansion, R&D, and national security production within the missile segment. L3Harris is a major defense contractor with a focus on communications, mission systems, and missile related...
NYSE:MKL
NYSE:MKLInsurance

Is Markel Group (MKL) Pricing Reflect Its Mixed Returns And Intrinsic Value Estimates

Wondering if Markel Group at around US$1,929.91 is offering fair value or a potential mispricing opportunity? This article walks through the key numbers so you can judge for yourself. The stock has seen mixed returns, with a 1.9% decline over the last 7 days, a 1.7% gain over 30 days, and a 6.7% return over 1 year. The longer 3 year and 5 year returns sit at 45.8% and 64.4% respectively. These moves sit against a backdrop of ongoing attention on Markel Group as an insurance and investment...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is It Too Late To Consider American Superconductor (AMSC) After A 129% One-Year Surge?

Wondering if American Superconductor at around US$46.15 is still offering value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen sharp moves recently, with returns of 21.5% over 7 days, 43.3% over 30 days, 46.1% year to date and 129.3% over 1 year, along with a very large 3 year return that sits above 7x. These moves come as American Superconductor continues to attract attention from investors looking at power...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Assessing T. Rowe Price (TROW) Valuation After Expanded 55ip Tax Optimization Partnership

Fresh attention is turning to T. Rowe Price Group (TROW) after 55ip, a J.P. Morgan subsidiary, expanded its collaboration with the asset manager to deliver tax-focused custom model portfolios for financial advisors. See our latest analysis for T. Rowe Price Group. The dual-share class approval and the expanded 55ip partnership come as T. Rowe Price Group’s share price sits at US$99.49, with a 12.04% 1 month share price return but a 5 year total shareholder return of negative 31.28%. This...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Margin Strength And 17% Earnings Growth Test Bullish Narratives

Kinder Morgan (KMI) opened 2026 with Q1 results that build on a solid recent run, with Q4 2025 revenue at US$4.5 billion and basic EPS of US$0.45 supported by net income of US$991 million. Over the past few quarters, revenue has moved from US$3.7 billion in Q3 2024 to US$4.0 billion in Q2 2025 and US$4.5 billion in Q4 2025, while basic EPS shifted from US$0.28 to US$0.32 and then to US$0.45. Together, these figures give you a clear sense of the recent earnings trajectory. With a trailing net...
NYSE:NLY
NYSE:NLYMortgage REITs

Is It Too Late To Consider Annaly Capital Management (NLY) After Its Recent Share Price Run?

If you are wondering whether Annaly Capital Management's share price still reflects fair value after a strong run, this article walks through what the current numbers may be saying about the stock. The stock last closed at US$22.43, with returns of 1.3% over 7 days, 6.4% over 30 days, a 2.1% decline year to date, 35.7% over 1 year, 70.0% over 3 years and 21.4% over 5 years. Recent coverage has focused on Annaly Capital Management's position within the mortgage REIT space and how interest...
NYSE:WEC
NYSE:WECIntegrated Utilities

Is It Too Late To Consider WEC Energy Group (WEC) After Recent Utility Sector Focus?

Wondering if WEC Energy Group at around US$115.57 is offering fair value or if you are paying up for a premium utility stock? This article unpacks the numbers so you can judge how its current price compares across several valuation lenses. The stock has returned 2.2% over the last 30 days and 8.5% year to date, with a 9.7% return over the past year and longer-term gains of 33.3% over 3 years and 42.7% over 5 years. Recent attention on utilities and power infrastructure has kept investor...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Plexus (PLXS) Valuation Check After Investor Letter Highlights Semiconductor Robotics And Healthcare Momentum

Why an Investor Letter Put Plexus (PLXS) Back on Investors’ Radar Recent commentary in Riverwater Partners’ Q1 2026 investor letter has put Plexus (PLXS) in focus, highlighting activity related to semiconductor equipment demand, new robotics wins, and fresh healthcare orders. See our latest analysis for Plexus. Plexus shares have moved sharply higher in recent months, with a 43.6% 90 day share price return and 99.3% 1 year total shareholder return. This suggests momentum has been building as...
NYSE:WAL
NYSE:WALBanks

Western Alliance Addresses Fraud Losses And Resets Deposit Growth And Valuation

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

EZCORP (EZPW) Is Up 5.8% After Record FY2024 Results And Pawn Loan Growth - Has The Bull Case Changed?

In its recently reported fiscal Q4 and full-year 2024 results, EZCORP announced record revenue and EBITDA margins, 11% year-over-year Q4 revenue growth, a 14% increase in pawn loans outstanding, and the addition of 21 stores across five countries. Management also highlighted rapid uptake of EZ+ Rewards and online payment options alongside a strong mergers-and-acquisitions pipeline, signaling an intensified push to scale both its physical footprint and digital customer channels. We’ll now...
NYSE:MNSO
NYSE:MNSOMultiline Retail

A Look At MINISO Group Holding’s Valuation As The CEO Plans A HK$50 Million Share Purchase

MINISO Group Holding (MNSO) has drawn fresh attention after Chairman and CEO Guofu Ye announced plans to buy at least HK$50.0 million of shares with personal funds over the next year. See our latest analysis for MINISO Group Holding. Despite the chairman’s planned HK$50.0 million share purchase, recent momentum has been weak. The latest 30 day share price return of 11.26% and a 1 year total shareholder return of 12.34% point to fading gains. If this insider move has you rethinking where...
NYSE:FLR
NYSE:FLRConstruction

Fluor’s Shift To Reimbursable Contracts And NuScale Monetization Might Change The Case For Investing In Fluor (FLR)

Fluor Corporation recently advanced its transformation from a fixed-price engineering and construction contractor to a more predictable reimbursable-services platform, rebuilding its backlog with higher-quality, lower-volatility contracts. An interesting development is that Fluor is funding a large share repurchase program partly by monetizing its NuScale stake, aiming to make earnings more capital-efficient and shareholder-focused. We’ll now examine how Fluor’s pivot toward reimbursable,...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

A Look At Spyre Therapeutics (SYRE) Valuation After Positive SKYLINE Data And Strong Buy Analyst Initiation

Spyre Therapeutics (SYRE) is back on investors' radar after reporting positive 12-week induction data from Part A of its Phase 2 SKYLINE trial for SPY001 in moderate to severely active ulcerative colitis. See our latest analysis for Spyre Therapeutics. The positive SKYLINE data landed alongside a $403 million follow on equity offering. Despite a 5.15% 1 day share price decline to $69.24, Spyre still shows a 64.0% 30 day share price return and a very large 3 year total shareholder return. This...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Is JDcom (NasdaqGS:JD) Still Attractive After Recent Share Price Rebound

If you are wondering whether JD.com's current share price still offers value or if most of the opportunity is already priced in, this article breaks down what the market is paying for and what that might mean for you. The stock closed at US$29.98, with a 9.1% gain over 30 days, a 4.3% decline over 7 days, a 1.5% return year to date, and longer term returns of a 4.4% decline over 1 year, a 5.6% decline over 3 years, and a 56.2% decline over 5 years. Recent coverage around JD.com has focused...
NYSE:ITT
NYSE:ITTMachinery

Assessing ITT (ITT) Valuation After Strong Recent Share Price Momentum

Why ITT (ITT) Is On Investors’ Radar Today ITT (ITT) has drawn attention after recent share price strength, with the stock closing at $219.10 and showing positive returns over the past week, month and past 3 months. With a market value of about $19.4b and a footprint across transportation, industrial and energy markets, the company’s recent performance is prompting investors to reassess how current pricing lines up with its fundamentals. See our latest analysis for ITT. ITT’s recent share...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

Solid Q1 Earnings and Fleet Upgrades Might Change The Case For Investing In SkyWest (SKYW)

SkyWest, Inc. reported past first-quarter 2026 results with revenue of US$1,013.18 million and net income of US$101.69 million, slightly higher than a year earlier, alongside modestly higher earnings per share. The company paired this earnings growth with continued debt reduction, strong free cash flow use, and fleet upgrades including new E175 deliveries and upcoming CRJ450 conversions for United. Now we’ll examine how this combination of solid earnings and fleet expansion may influence...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Is It Too Late To Consider Cytokinetics (CYTK) After Its 62% One-Year Surge?

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron’s Wheatstone Restart And Venezuela Shift Versus Current Valuation

Chevron has resumed full production at its Wheatstone LNG facility in Australia after repairs related to cyclone damage. The company has completed an asset swap in Venezuela that increases its stake in heavy oil operations. Both moves come as global energy trade is being reshaped by geopolitical tension and shifting supply routes. For investors tracking NYSE:CVX, these operational updates arrive with the stock trading at $187.6 and showing a 20.3% return year to date and 41.0% over the past...
NYSE:CNC
NYSE:CNCHealthcare

Is It Time To Reassess Centene (CNC) After Its Recent Share Price Rebound

Investors may be asking whether Centene's current share price reflects its true worth, or if the recent weakness could be setting up a more interesting entry point. Centene's stock closed at US$41.09, with a 5.4% gain over the last 7 days and a 24.6% gain over the last 30 days, while returns sit at a 1.7% decline year to date and a 33.3% decline over the past year. Recent news around Centene has focused on its position in managed care and healthcare services, as investors weigh how policy,...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

Assessing CareDx (CDNA) Valuation As Recent Share Price Swings Draw Investor Attention

Why CareDx Stock Is on Investors’ Radar Now CareDx (CDNA) has drawn attention after recent share price swings, with a 2.8% decline over the past day, a 10.5% drop over the past week, and a 12.4% gain over the past month. See our latest analysis for CareDx. Beyond the latest swings, CareDx’s 1 month share price return of 12.44% contrasts with a 4.81% year to date share price gain. The 3 year total shareholder return is very large, suggesting sentiment has shifted more meaningfully over a...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Corpay’s Toulouse FC Deal And What It Could Mean For NYSE CPAY

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...